(36) Kasdan TS. Medical Nutrition Therapy for Anaemia. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, and Diet Therapy.

Transcription

1 Reference List (1) Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 9th ed. Oxford: Blackwell Scientific, (2) Wanless IR. Anatomy, Histology, Embryology, and Developmental Anomalies of the Liver. In: Feldman M FLSM, editor. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. (3) Morgan MY. Nutritional Aspects of Liver and Biliary Disease. In: Bircher J BJ-PMNRMRJ, editor. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (4) Stolz A. Liver Physiology and Metabolic Function. In: Feldman M FLSM, editor. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. (5) Mizock BA. Nutritional support in hepatic encephalopathy. Nutrition 1999; 15(3): (6) Muller MJ, Pirlich M, Balks HJ, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and nonhepatic influences. Eur J Clin Chem Clin Biochem 1994; 32(10): (7) Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 1974; 127(1): (8) Korsten MA, Lieber CS. Nutrition in Pancreatic and Liver Disorders. In: Shils et al., editor. Modern Nutrition in Health and Disease. London: Lea & Febiger, (9) Gerber T, Schomerus H. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management. Drugs 2000; 60(6): (10) Arroyo V, Gines P, Jimenez W, Rodes J. Renal Dysfunction in Cirrhosis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (11) Berengeuer M, Wright TL. Viral Hepatitis. (Eds). In: Feldman M, Friedman LS, Sleisenger MH, editors. (12) Gerlich WH, Thomssen R. The Viruses of Hepatitis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (13) Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis. BMJ 2001; 322(7279): (14) Dusheiko G. Hepatitis B. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (15) Bayless TM. Current Therapy in Gastroenterology and Liver Disease. 4 ed. London: Mosby, (16) Hasse JM, Matarese LE. Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, & Diet Therapy. London: WB Saunders Company, (17) Popper H. Viral Hepatitis 1. Acute Form. In: Netter FH, editor. The Ciba Collection of Medical Illustrations. Part III. Liver, Biliary Tract and Pancreas. Cincinatti: The Hennegan Company, (18) Leevy CM, Sherlock S, Tygstruo N, Zetterman R. Diseases of the Liver, and Biliary Tract. New York: Raven Press, (19) Piche T, Schneider SM, Tran A, Benzaken S, Rampal P, Hebuterne X. Resting energy expenditure in chronic hepatitis C. J Hepatol 2000; 33(4): (20) Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993; 22(2): (21) Wicks C. Nutrition and Liver Disease. In: Payne-James J, Grimble G, Silk D, editors. Artificial Nutrition Support in Clinical Practice. London: Greenwich Medical Media Limited, (22) Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J 2000; 76(895): (23) Tuyns AJ, Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984; 13(1): (24) Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41(6): (25) Maher JJ. Alcoholic Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. London: Saunders, (26) Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346(8981): (27) Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2002; 2(1): (28) Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17 Suppl:S186-S190. (29) Diehl AM, Poordad F. Nonalcoholic Fatty Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (30) Zakim D, Boyer T. Hepatology. A Textbook of Liver Disease. 2 ed. London: WB Saunders, (31) Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol 2002; 16(5): (32) Youssef WI, McCullough AJ. Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol 2002; 16(5): (33) Cox DW, Roberts EA. Wilson Disease. (Eds). In: Feldman M, Friedman LS, Sleisenger MH, editors. (34) Bacon BR, Britton RS. Hereditary Hemochromatosis. In: Feldman M, Friedman LS, Sleisenger MH, editors. (35) Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991; 90(4):

2 (36) Kasdan TS. Medical Nutrition Therapy for Anaemia. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, and Diet Therapy. London: WB Saunders Company, (37) Mihas AA. Cirrhosis and the liver. Postgraduate Med 2001; 109: (38) Erlinger S, Benhamou J-P. Cirrhosis: Clinical Aspects. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (39) Whitney EN, Cataldo C, DeBruyne LK, Rolfes SR. Nutrition for Health and Health Care. 2 ed. London: Wadsworth, (40) Gonzalez-Abraldes J, Garcia-Pagan JC, Bosch J. Nitric oxide and portal hypertension. Metab Brain Dis 2002; 17(4): (41) Witte CL, Witte MH, Dumont AE, Frist J, Cole WR. Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension. Ann Surg 1968; 168(4): (42) Yablonski ME, Lifson N. Mechanism of production of intestinal secretion by elevated venous pressure. J Clin Invest 1976; 57(4): (43) Davern TJ, Scharschmidt BF. Biochemical Liver Tests. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (44) Beckingham IJ, Ryder SD. ABC of diseases of liver, pancreas, and biliary system. Investigation of liver and biliary disease. BMJ 2001; 322(7277): (45) Hegab AM, Luketic VA. Bleeding esophageal varices. How to treat this dreaded complication of portal hypertension. Postgrad Med 2001; 109(2):75-6, 89. (46) Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension-1: varices. BMJ 2001; 322(7282): (47) Luca A, Garcia-Pagan JC, Bosch J, Feu F, Caballeria J, Groszmann RJ et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112(4): (48) Ready JB, Hossack KF, Rector WG, Jr. The effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis. Hepatology 1990; 11(4): (49) Silva G, Fluxa F, Bresky G, Backhouse C, Palma M, Ruiz M et al. Splanchnic and systemic hemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients. J Hepatol 1994; 20(4): (50) Sugano S, Kawafune T, Okajima T, Ishii K, Watanabe M, Takamura N. Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis. Dig Dis Sci 1998; 43(4): (51) Hawker F. The Liver. London: WB Saunders Co Ltd, (52) Arroyo V, Gines P, Planas R, Rodés. Pathogenesis, Diagnosis, and Treatment of Ascites in Cirrhosis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodés J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (53) Magri P, Auletta M, Andreucci M, Somma G, Musone D, Fiorillo M et al. Sodium retention in preascitic stage of cirrhosis. Semin Nephrol 2001; 21(3): (54) Runyon BA. Ascites and Spontaneous Bacterial Peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (55) Garcia N, Jr., Sanyal AJ. Minimizing ascites. Complication of cirrhosis signals clinical deterioration. Postgrad Med 2001; 109(2): (56) Casafont F, Sanchez E, Martin L, Aguero J, Romero FP. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology 1997; 25(6): (57) Dolz C, Raurich JM, Ibanez J, Obrador A, Marse P, Gaya J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 1991; 100(3): (58) Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30(4): (59) Dioguardi FS. Nutritional and hemodynamic implications of large volumes paracentesis in cirrhotics. Eur Rev Med Pharmacol Sci 1997; 1(1-3): (60) Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, Hepatology 2002; 35(3): (61) Abou-Assi S, Vlahcevic ZR. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible. Postgrad Med 2001; 109(2):52-60, 63. (62) Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol 2001; 96(7): (63) Hawkins RA, Jessy J, Mans AM, Chedid A, DeJoseph MR. Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol 1994; 368: (64) Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16(3): (65) Grippon P, Le Poncin LM, Boschat M, Wang S, Faure G, Dutertre D et al. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology 1986; 6(4): (66) Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis 1996; 16(3): (67) Stahl J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med 1963; 58:1-24. (68) Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11(2): (69) Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31(1): (70) Hindfelt B, Plum F, Duffy TE. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 1977; 59(3):

3 (71) Theoret Y, Bossu JL. Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells in vivo. Neuroscience 1985; 14(3): (72) de Knegt RJ, Schalm SW, van der Rijt CC, Fekkes D, Dalm E, Hekking-Weyma I. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J Hepatol 1994; 20(1): (73) Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991; 261(3 Pt 2):H825-H829. (74) Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78(3): (75) Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80(1): (76) Schafer DF, Jones EA. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet 1982; 1(8262): (77) Levy LJ, Losowsky MS. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease. Hepatogastroenterology 1989; 36(6): (78) Thompson JS, Schafer DF, Schafer GJ, Hodgson PE. gamma-aminobutyric acid plasma levels and brain binding in Eck fistula dogs. J Surg Res 1985; 38(2): (79) Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991; 13(2): (80) Pardridge WM. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 1977; 28(1): (81) Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346(8970): (82) Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117(3): (83) van der Rijt CC, Schalm SW, Schat H, Foeken K, De Jong G. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology 1991; 100(4): (84) Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991; 36(9): (85) Read AE, Laidlaw J, Haslam RM, Sherlock S. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin Sci 1959; 18: (86) Farinati F, De Bona M, Floreani A, Foschia F, Rugge M. Helicobacter pylori and the liver: any relationship? Ital J Gastroenterol Hepatol 1998; 30(1): (87) Vasconez C, Elizalde JI, Llach J, Gines A, de la RC, Fernandez RM et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30(2): (88) Fitz JG. Hepatic Encephalopathy, Hepatopulmonary Syndromes, Hepatorenal Syndrome, Coagulopathy, and Endocrine Complications of Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. (89) Bircher J, Scollo-Lavizzari G, Hoffmann K, Haemmerli UP. [Treatment of chronic porto-systemic encephalopathy with lactulose]. Schweiz Med Wochenschr 1969; 99(16):584. (90) Clausen MR, Jorgensen J, Mortensen PB. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig Dis Sci 1998; 43(12): (91) Fernandes J, Morali G, Wolever TM, Blendis LM, Koo M, Jenkins DJ et al. Effect of acute lactulose administration on serum acetate levels in cirrhosis. Clin Invest Med 1994; 17(3): (92) Huchzermeyer H, Schumann C. Lactulose--a multifaceted substance. Z Gastroenterol 1997; 35(10): (93) Berk DP, Chalmers T. Deafness complicating antibiotic therapy of hepatic encephalopathy. Ann Intern Med 1970; 73(3): (94) Morgan MH, Read AE, Speller DC. Treatment of hepatic encephalopathy with metronidazole. Gut 1982; 23(1):1-7. (95) Loft S, Sonne J, Dossing M, Andreasen PB. Metronidazole pharmacokinetics in patients with hepatic encephalopathy. Scand J Gastroenterol 1987; 22(1): (96) Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmuller E, Holm E. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 1993; 19(3): (97) Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R et al. Therapeutic efficacy of L-ornithine- L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997; 25(6): (98) Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol 1998; 28(5): (99) Lochs H, Plauth M. Liver cirrhosis: rationale and modalities for nutritional support--the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999; 2(4): (100) Zillikens MC, van den Berg JW, Wilson JH, Swart GR. Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites. Am J Clin Nutr 1992; 55(3):

4 (101) Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995; 19(4): (102) Pomposelli JJ, Burns DL. Nutrition support in the liver transplant patient. Nutr Clin Pract 2002; 17: (103) Mills PR, Shenkin A, Anthony RS, McLelland AS, Main AN, MacSween RN et al. Assessment of nutritional status and in vivo immune responses in alcoholic liver disease. Am J Clin Nutr 1983; 38(6): (104) O'Keefe SJ, El Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 1980; 2(8195 pt 1): (105) Morgan AG, Kelleher J, Walker BE, Losowsky MS. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 1976; 17(2): (106) Charleton MR. Branched chains revisited. Gastroenterology 1996; 111:252. (107) Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001; 17(9): (108) Morgan MY. Enteral nutrition in chronic liver disease. Acta Chir Scand Suppl 1981; 507: (109) Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17(4): (110) Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992; 70(6): (111) Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clinical nutrition 1997; 16(2): (112) Scolapio JS, Ukleja A, McGreevy K, Burnett OL, O'Brien PC. Nutritional problems in end-stage liver disease: contribution of impaired gastric emptying and ascites. J Clin Gastroenterol 2002; 34(1): (113) Mahan LK, Escott-Stump S. Krause's Food, Nutrition, & Diet Therapy. 10 ed. London: WB Saunders Company, (114) Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15(5): (115) Patek AJ, Post J, Ratnoff OF, Mankin H, Hillman RW. Dietary treatment of cirrhosis of the liver. JAMA 1948; 139: (116) Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 233(5): (117) Uribe M, Marquez MA, Garcia RG, Ramos-Uribe MH, Vargas F, Villalobos A et al. Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982; 27(12): (118) Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984; 4(2): (119) Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 1990; 11(1): (120) Naylor CD, O'Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989; 97(4): (121) Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr 1996; 20(2): (122) Fischer JE. Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology. JPEN J Parenter Enteral Nutr 1990; 14(5 Suppl):249S-256S. (123) Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. JPEN J Parenter Enteral Nutr 1997; 21(3): (124) Morgan MH, Bolton CH, Morris JS, Read AE. Medium chain triglycerides and hepatic encephalopathy. Gut 1974; 15(3): (125) Muscaritoli M, Cangiano C, Cascino A, Ceci F, Caputo V, Martino P et al. Exogenous lipid clearance in compensated liver cirrhosis. JPEN J Parenter Enteral Nutr 1986; 10(6): (126) Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defences with intralipid. Lancet 1980; 2(8199): (127) Muller JM, Keller HW, Brenner U, Walter M, Holzmuller W. Indications and effects of preoperative parenteral nutrition. World J Surg 1986; 10(1): (128) Negro F, Cerra FB. Nutritional monitoring in the ICU: rational and practical application. Crit Care Clin 1988; 4(3): (129) Chang N, Kim E, Kim SY, Jeong BS. Study of the relation between proton magnetic resonance spectroscopy metabolites in the brain regions and the B vitamin status in alcoholics. Nutrition Research 2001; 21(6): (130) Leevy CM, Thompson A, Baker H. Vitamins and liver injury. Am J Clin Nutr 1970; 23(4): (131) McClain CJ, Marsano L, Burk RF, Bacon B. Trace metals in liver disease. Semin Liver Dis 1991; 11(4): (132) Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16(3): (133) Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337(7): (134) Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23(5):

5 (135) Bianchi GP, Marchesini G, Brizi M, Rossi B, Forlani G, Boni P et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutrition Research 2000; 20(8): (136) Isobe H, Sakai H, Satoh M, Sakamoto S, Nawata H. Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 1994; 39(5): (137) Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102(1): (138) De L, V, Beau P, Mannant PR, Borderie C, Ripault MP, Silvain C et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci 1997; 42(3): (139) Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982; 2(4): (140) Shaw BW, Jr., Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5(4): (141) Reilly J, Mehta R, Teperman L, Cemaj S, Tzakis A, Yanaga K et al. Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990; 14(4): (142) Wicks C, Bray G, Williams R. Nutritional assessment in primary biliary cirrhosis. The effect of disease progression. Clin Nutr 1995; 14: (143) Weimann A, Kuse ER, Bechstein WO, Neuberger JM, Plauth M, Pichlmayr R. Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant units. Transpl Int 1998; 11 Suppl 1:S289-S291. (144) Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992; 56(1): (145) Oates JA, Wood AJJ. Cyclosporine. N Engl J Med 1989; 321: (146) Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA et al. Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 1998; 22(3): (147) Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Banares F et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98(3): (148) Ichida T, Shibasaki K, Muto Y, Satoh S, Watanabe A, Ichida F. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy. Nutrition 1995; 11(2 Suppl): (149) Tangkijvanich P, Mahachai V, Wittayalertpanya S, Ariyawongsopon V, Isarasena S. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients. Southeast Asian J Trop Med Public Health 2000; 31(1): (150) Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 1999; 69(11): (151) Mezey E, Caballeria J, Mitchell MC, Pares A, Herlong HF, Rodes J. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991; 14(6): (152) Hirsch S, Bunout D, de la MP, Iturriaga H, Petermann M, Icazar G et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN J Parenter Enteral Nutr 1993; 17(2): (153) Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 1991; 86(9): (154) Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol 1991; 86(9):